VBL Therapeutics Presents Two Studies on Novel Anti-Angiogenic Vector at 102nd Annual AACR Meeting

Press/Media: Press / Media

PeriodNov 20 2016

Media coverage

1

Media coverage

  • TitleVBL Therapeutics Presents Two Studies on Novel Anti-Angiogenic Vector at 102nd Annual AACR Meeting
    Media name/outletPitango Venture Capital
    CountryIsrael
    Date11/20/16
    PersonsAndrew Brenner